Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Growth (Status and Outlook) 2025-2031

October 2025 | 112 pages | ID: G6404096DF67EN
LP Information

Abstracts

According to this study, the global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market size will reach US$ million by 2031.

United States market for Post-Polycythemia Vera Myelofibrosis (PPV-MF) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Post-Polycythemia Vera Myelofibrosis (PPV-MF) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Post-Polycythemia Vera Myelofibrosis (PPV-MF) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Post-Polycythemia Vera Myelofibrosis (PPV-MF) players cover AbbVie Inc, Celgene Corp, CTI BioPharma Corp, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the ?Post-Polycythemia Vera Myelofibrosis (PPV-MF) Industry Forecast? looks at past sales and reviews total world Post-Polycythemia Vera Myelofibrosis (PPV-MF) sales in 2024, providing a comprehensive analysis by region and market sector of projected Post-Polycythemia Vera Myelofibrosis (PPV-MF) sales for 2025 through 2031. With Post-Polycythemia Vera Myelofibrosis (PPV-MF) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Post-Polycythemia Vera Myelofibrosis (PPV-MF) industry.

This Insight Report provides a comprehensive analysis of the global Post-Polycythemia Vera Myelofibrosis (PPV-MF) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Post-Polycythemia Vera Myelofibrosis (PPV-MF) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Post-Polycythemia Vera Myelofibrosis (PPV-MF) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Post-Polycythemia Vera Myelofibrosis (PPV-MF).

This report presents a comprehensive overview, market shares, and growth opportunities of Post-Polycythemia Vera Myelofibrosis (PPV-MF) market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Durvalumab
• Givinostat
• Glasdegib
• Idelalisib
• IMG-7289
• Others

Segmentation by Application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AbbVie Inc
• Celgene Corp
• CTI BioPharma Corp
• F. Hoffmann-La Roche Ltd
• Gilead Sciences Inc
• Incyte Corp
• Italfarmaco SpA
• JW Pharmaceutical Corp
• MedImmune LLC
• MEI Pharma Inc
• Merck & Co Inc
• Novartis AG
• NS Pharma Inc
• Promedior Inc
• Sun Pharma Advanced Research Company Ltd

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size (2020-2031)
  2.1.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Post-Polycythemia Vera Myelofibrosis (PPV-MF) by Country/Region (2020, 2024 & 2031)
2.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Segment by Type
  2.2.1 Durvalumab
  2.2.2 Givinostat
  2.2.3 Glasdegib
  2.2.4 Idelalisib
  2.2.5 IMG-7289
  2.2.6 Others
2.3 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type
  2.3.1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Type (2020-2025)
2.4 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Others
2.5 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application
  2.5.1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Application (2020-2025)

3 POST-POLYCYTHEMIA VERA MYELOFIBROSIS (PPV-MF) MARKET SIZE BY PLAYER

3.1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Player
  3.1.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue by Player (2020-2025)
  3.1.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share by Player (2020-2025)
3.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 POST-POLYCYTHEMIA VERA MYELOFIBROSIS (PPV-MF) BY REGION

4.1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Region (2020-2025)
4.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth (2020-2025)
4.4 APAC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth (2020-2025)
4.5 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth (2020-2025)
4.6 Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2020-2025)
5.2 Americas Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2020-2025)
5.3 Americas Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Region (2020-2025)
6.2 APAC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2020-2025)
6.3 APAC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2020-2025)
7.2 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2020-2025)
7.3 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) by Region (2020-2025)
8.2 Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2020-2025)
8.3 Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL POST-POLYCYTHEMIA VERA MYELOFIBROSIS (PPV-MF) MARKET FORECAST

10.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast by Region (2026-2031)
  10.1.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast by Region (2026-2031)
  10.1.2 Americas Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
  10.1.3 APAC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
  10.1.4 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
  10.1.5 Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
10.2 Americas Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast by Country (2026-2031)
  10.2.1 United States Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
  10.2.2 Canada Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
  10.2.3 Mexico Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
  10.2.4 Brazil Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
10.3 APAC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast by Region (2026-2031)
  10.3.1 China Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Forecast
  10.3.2 Japan Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
  10.3.3 Korea Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
  10.3.4 Southeast Asia Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
  10.3.5 India Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
  10.3.6 Australia Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
10.4 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast by Country (2026-2031)
  10.4.1 Germany Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
  10.4.2 France Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
  10.4.3 UK Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
  10.4.4 Italy Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
  10.4.5 Russia Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
10.5 Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast by Region (2026-2031)
  10.5.1 Egypt Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
  10.5.2 South Africa Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
  10.5.3 Israel Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
  10.5.4 Turkey Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
10.6 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast by Type (2026-2031)
10.7 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast

11 KEY PLAYERS ANALYSIS

11.1 AbbVie Inc
  11.1.1 AbbVie Inc Company Information
  11.1.2 AbbVie Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
  11.1.3 AbbVie Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 AbbVie Inc Main Business Overview
  11.1.5 AbbVie Inc Latest Developments
11.2 Celgene Corp
  11.2.1 Celgene Corp Company Information
  11.2.2 Celgene Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
  11.2.3 Celgene Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Celgene Corp Main Business Overview
  11.2.5 Celgene Corp Latest Developments
11.3 CTI BioPharma Corp
  11.3.1 CTI BioPharma Corp Company Information
  11.3.2 CTI BioPharma Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
  11.3.3 CTI BioPharma Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 CTI BioPharma Corp Main Business Overview
  11.3.5 CTI BioPharma Corp Latest Developments
11.4 F. Hoffmann-La Roche Ltd
  11.4.1 F. Hoffmann-La Roche Ltd Company Information
  11.4.2 F. Hoffmann-La Roche Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
  11.4.3 F. Hoffmann-La Roche Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 F. Hoffmann-La Roche Ltd Main Business Overview
  11.4.5 F. Hoffmann-La Roche Ltd Latest Developments
11.5 Gilead Sciences Inc
  11.5.1 Gilead Sciences Inc Company Information
  11.5.2 Gilead Sciences Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
  11.5.3 Gilead Sciences Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Gilead Sciences Inc Main Business Overview
  11.5.5 Gilead Sciences Inc Latest Developments
11.6 Incyte Corp
  11.6.1 Incyte Corp Company Information
  11.6.2 Incyte Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
  11.6.3 Incyte Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Incyte Corp Main Business Overview
  11.6.5 Incyte Corp Latest Developments
11.7 Italfarmaco SpA
  11.7.1 Italfarmaco SpA Company Information
  11.7.2 Italfarmaco SpA Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
  11.7.3 Italfarmaco SpA Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Italfarmaco SpA Main Business Overview
  11.7.5 Italfarmaco SpA Latest Developments
11.8 JW Pharmaceutical Corp
  11.8.1 JW Pharmaceutical Corp Company Information
  11.8.2 JW Pharmaceutical Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
  11.8.3 JW Pharmaceutical Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 JW Pharmaceutical Corp Main Business Overview
  11.8.5 JW Pharmaceutical Corp Latest Developments
11.9 MedImmune LLC
  11.9.1 MedImmune LLC Company Information
  11.9.2 MedImmune LLC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
  11.9.3 MedImmune LLC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 MedImmune LLC Main Business Overview
  11.9.5 MedImmune LLC Latest Developments
11.10 MEI Pharma Inc
  11.10.1 MEI Pharma Inc Company Information
  11.10.2 MEI Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
  11.10.3 MEI Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 MEI Pharma Inc Main Business Overview
  11.10.5 MEI Pharma Inc Latest Developments
11.11 Merck & Co Inc
  11.11.1 Merck & Co Inc Company Information
  11.11.2 Merck & Co Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
  11.11.3 Merck & Co Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Merck & Co Inc Main Business Overview
  11.11.5 Merck & Co Inc Latest Developments
11.12 Novartis AG
  11.12.1 Novartis AG Company Information
  11.12.2 Novartis AG Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
  11.12.3 Novartis AG Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Novartis AG Main Business Overview
  11.12.5 Novartis AG Latest Developments
11.13 NS Pharma Inc
  11.13.1 NS Pharma Inc Company Information
  11.13.2 NS Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
  11.13.3 NS Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 NS Pharma Inc Main Business Overview
  11.13.5 NS Pharma Inc Latest Developments
11.14 Promedior Inc
  11.14.1 Promedior Inc Company Information
  11.14.2 Promedior Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
  11.14.3 Promedior Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Promedior Inc Main Business Overview
  11.14.5 Promedior Inc Latest Developments
11.15 Sun Pharma Advanced Research Company Ltd
  11.15.1 Sun Pharma Advanced Research Company Ltd Company Information
  11.15.2 Sun Pharma Advanced Research Company Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
  11.15.3 Sun Pharma Advanced Research Company Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 Sun Pharma Advanced Research Company Ltd Main Business Overview
  11.15.5 Sun Pharma Advanced Research Company Ltd Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Durvalumab
Table 4. Major Players of Givinostat
Table 5. Major Players of Glasdegib
Table 6. Major Players of Idelalisib
Table 7. Major Players of IMG-7289
Table 8. Major Players of Others
Table 9. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2020-2025) & ($ millions)
Table 11. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Type (2020-2025)
Table 12. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2020-2025) & ($ millions)
Table 14. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Application (2020-2025)
Table 15. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue by Player (2020-2025) & ($ millions)
Table 16. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share by Player (2020-2025)
Table 17. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Key Players Head office and Products Offered
Table 18. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Region (2020-2025) & ($ millions)
Table 22. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Region (2020-2025)
Table 23. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Country (2020-2025)
Table 27. Americas Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2020-2025) & ($ millions)
Table 28. Americas Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Type (2020-2025)
Table 29. Americas Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2020-2025) & ($ millions)
Table 30. Americas Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Application (2020-2025)
Table 31. APAC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Region (2020-2025)
Table 33. APAC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2020-2025) & ($ millions)
Table 34. APAC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2020-2025) & ($ millions)
Table 35. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Country (2020-2025)
Table 37. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2020-2025) & ($ millions)
Table 38. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2020-2025) & ($ millions)
Table 39. Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2020-2025) & ($ millions)
Table 41. Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Post-Polycythemia Vera Myelofibrosis (PPV-MF)
Table 43. Key Market Challenges & Risks of Post-Polycythemia Vera Myelofibrosis (PPV-MF)
Table 44. Key Industry Trends of Post-Polycythemia Vera Myelofibrosis (PPV-MF)
Table 45. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Forecast by Region (2026-2031) & ($ millions)
Table 46. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share Forecast by Region (2026-2031)
Table 47. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Forecast by Type (2026-2031) & ($ millions)
Table 48. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Forecast by Application (2026-2031) & ($ millions)
Table 49. AbbVie Inc Details, Company Type, Post-Polycythemia Vera Myelofibrosis (PPV-MF) Area Served and Its Competitors
Table 50. AbbVie Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
Table 51. AbbVie Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. AbbVie Inc Main Business
Table 53. AbbVie Inc Latest Developments
Table 54. Celgene Corp Details, Company Type, Post-Polycythemia Vera Myelofibrosis (PPV-MF) Area Served and Its Competitors
Table 55. Celgene Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
Table 56. Celgene Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. Celgene Corp Main Business
Table 58. Celgene Corp Latest Developments
Table 59. CTI BioPharma Corp Details, Company Type, Post-Polycythemia Vera Myelofibrosis (PPV-MF) Area Served and Its Competitors
Table 60. CTI BioPharma Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
Table 61. CTI BioPharma Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. CTI BioPharma Corp Main Business
Table 63. CTI BioPharma Corp Latest Developments
Table 64. F. Hoffmann-La Roche Ltd Details, Company Type, Post-Polycythemia Vera Myelofibrosis (PPV-MF) Area Served and Its Competitors
Table 65. F. Hoffmann-La Roche Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
Table 66. F. Hoffmann-La Roche Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. F. Hoffmann-La Roche Ltd Main Business
Table 68. F. Hoffmann-La Roche Ltd Latest Developments
Table 69. Gilead Sciences Inc Details, Company Type, Post-Polycythemia Vera Myelofibrosis (PPV-MF) Area Served and Its Competitors
Table 70. Gilead Sciences Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
Table 71. Gilead Sciences Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. Gilead Sciences Inc Main Business
Table 73. Gilead Sciences Inc Latest Developments
Table 74. Incyte Corp Details, Company Type, Post-Polycythemia Vera Myelofibrosis (PPV-MF) Area Served and Its Competitors
Table 75. Incyte Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
Table 76. Incyte Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. Incyte Corp Main Business
Table 78. Incyte Corp Latest Developments
Table 79. Italfarmaco SpA Details, Company Type, Post-Polycythemia Vera Myelofibrosis (PPV-MF) Area Served and Its Competitors
Table 80. Italfarmaco SpA Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
Table 81. Italfarmaco SpA Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. Italfarmaco SpA Main Business
Table 83. Italfarmaco SpA Latest Developments
Table 84. JW Pharmaceutical Corp Details, Company Type, Post-Polycythemia Vera Myelofibrosis (PPV-MF) Area Served and Its Competitors
Table 85. JW Pharmaceutical Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
Table 86. JW Pharmaceutical Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. JW Pharmaceutical Corp Main Business
Table 88. JW Pharmaceutical Corp Latest Developments
Table 89. MedImmune LLC Details, Company Type, Post-Polycythemia Vera Myelofibrosis (PPV-MF) Area Served and Its Competitors
Table 90. MedImmune LLC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
Table 91. MedImmune LLC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. MedImmune LLC Main Business
Table 93. MedImmune LLC Latest Developments
Table 94. MEI Pharma Inc Details, Company Type, Post-Polycythemia Vera Myelofibrosis (PPV-MF) Area Served and Its Competitors
Table 95. MEI Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
Table 96. MEI Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 97. MEI Pharma Inc Main Business
Table 98. MEI Pharma Inc Latest Developments
Table 99. Merck & Co Inc Details, Company Type, Post-Polycythemia Vera Myelofibrosis (PPV-MF) Area Served and Its Competitors
Table 100. Merck & Co Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
Table 101. Merck & Co Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 102. Merck & Co Inc Main Business
Table 103. Merck & Co Inc Latest Developments
Table 104. Novartis AG Details, Company Type, Post-Polycythemia Vera Myelofibrosis (PPV-MF) Area Served and Its Competitors
Table 105. Novartis AG Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
Table 106. Novartis AG Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 107. Novartis AG Main Business
Table 108. Novartis AG Latest Developments
Table 109. NS Pharma Inc Details, Company Type, Post-Polycythemia Vera Myelofibrosis (PPV-MF) Area Served and Its Competitors
Table 110. NS Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
Table 111. NS Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 112. NS Pharma Inc Main Business
Table 113. NS Pharma Inc Latest Developments
Table 114. Promedior Inc Details, Company Type, Post-Polycythemia Vera Myelofibrosis (PPV-MF) Area Served and Its Competitors
Table 115. Promedior Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
Table 116. Promedior Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 117. Promedior Inc Main Business
Table 118. Promedior Inc Latest Developments
Table 119. Sun Pharma Advanced Research Company Ltd Details, Company Type, Post-Polycythemia Vera Myelofibrosis (PPV-MF) Area Served and Its Competitors
Table 120. Sun Pharma Advanced Research Company Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offered
Table 121. Sun Pharma Advanced Research Company Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 122. Sun Pharma Advanced Research Company Ltd Main Business
Table 123. Sun Pharma Advanced Research Company Ltd Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales Market Share by Country/Region (2024)
Figure 8. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Type in 2024
Figure 10. Post-Polycythemia Vera Myelofibrosis (PPV-MF) in Hospital
Figure 11. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market: Hospital (2020-2025) & ($ millions)
Figure 12. Post-Polycythemia Vera Myelofibrosis (PPV-MF) in Clinic
Figure 13. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market: Clinic (2020-2025) & ($ millions)
Figure 14. Post-Polycythemia Vera Myelofibrosis (PPV-MF) in Others
Figure 15. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market: Others (2020-2025) & ($ millions)
Figure 16. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Application in 2024
Figure 17. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share by Player in 2024
Figure 18. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Region (2020-2025)
Figure 19. Americas Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2020-2025 ($ millions)
Figure 20. APAC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2020-2025 ($ millions)
Figure 21. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2020-2025 ($ millions)
Figure 23. Americas Post-Polycythemia Vera Myelofibrosis (PPV-MF) Value Market Share by Country in 2024
Figure 24. United States Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Region in 2024
Figure 29. APAC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Type (2020-2025)
Figure 30. APAC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Application (2020-2025)
Figure 31. China Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 35. India Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Country in 2024
Figure 38. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Type (2020-2025)
Figure 39. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Application (2020-2025)
Figure 40. Germany Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 41. France Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 54. APAC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 55. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 57. United States Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 58. Canada Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 59. Mexico Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 60. Brazil Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 61. China Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 62. Japan Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 63. Korea Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 65. India Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 66. Australia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 67. Germany Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 68. France Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 69. UK Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 70. Italy Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 71. Russia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 72. Egypt Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 73. South Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 74. Israel Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 75. Turkey Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)
Figure 76. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size 2026-2031 ($ millions)